Literature DB >> 2538796

Infantile spasms.

R A Hrachovy1, J D Frost.   

Abstract

Infantile spasms constitute a relatively rare disorder of infancy and early childhood; their onset is usually within the first 6 to 8 months of life. A large percentage of patients with this disorder (85-90 per cent) show various degrees of retardation. Infantile spasms typically occur in clusters immediately on arousal, or soon thereafter, but rarely occur while the infant is actually asleep. The usual interictal EEG pattern associated with infantile spasms is hypsarrhythmia, but infantile spasms may occur in the absence of this EEG pattern. The pathophysiology of infantile spasms is not known, but recent evidence suggests that certain regions in the brain stem that are associated with sleep cycling may be responsible for the clinical and EEG manifestations of this disorder. At present, the only known effective treatment for infantile spasms is ACTH or corticosteroids. The therapeutic efficacy of these two agents is relatively equal, and one drug may be effective if the other drug fails. The effectiveness of certain traditional anticonvulsants (valproic acid and the benzodiazepines) and pyridoxine in the treatment of infantile spasms has not been adequately assessed. The long-term mental and developmental outcome of patients with infantile spasms is poor. The only factor that appears to be important in terms of long-term outcome is whether the patient is initially classified as cryptogenic or symptomatic, with the cryptogenic patients having the better outcomes. Approximately half of the infantile spasm patients will continue to have other types of seizures after their spasms stop.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538796     DOI: 10.1016/s0031-3955(16)36651-2

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  14 in total

1.  Treatment of infantile spasms: the ideal and the mundane.

Authors:  Tallie Z Baram
Journal:  Epilepsia       Date:  2003-08       Impact factor: 5.864

Review 2.  Diagnosis and treatment of epilepsy in children and adolescents.

Authors:  L D Morton; J M Pellock
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

3.  ACTH induced adrenal enlargement in infants treated for infantile spasms and acute cerebellar encephalopathy.

Authors:  M S Liebling; T J Starc; W H McAlister; C B Ruzal-Shapiro; S J Abramson; W E Berdon
Journal:  Pediatr Radiol       Date:  1993

4.  Statistical mapping of ictal high-frequency oscillations in epileptic spasms.

Authors:  Hiroki Nariai; Tetsuro Nagasawa; Csaba Juhász; Sandeep Sood; Harry T Chugani; Eishi Asano
Journal:  Epilepsia       Date:  2010-11-18       Impact factor: 5.864

Review 5.  ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability.

Authors:  K L Brunson; S Avishai-Eliner; T Z Baram
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

Review 6.  How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis.

Authors:  K L Brunson; M Eghbal-Ahmadi; T Z Baram
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

Review 7.  What are the reasons for the strikingly different approaches to the use of ACTH in infants with West syndrome?

Authors:  T Z Baram
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

Review 8.  Immunoglobulin treatment in human and experimental epilepsy.

Authors:  B G van Engelen; W O Renier; C M Weemaes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

9.  High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study.

Authors:  B G van Engelen; W O Renier; C M Weemaes; P F Strengers; P J Bernsen; S L Notermans
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

Review 10.  Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms.

Authors:  D A Iacobas; S Iacobas; T Chachua; C Goletiani; G Sidyelyeva; J Velíšková; L Velíšek
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.